Common Contracts
5 similar null contracts by Rosetta Genomics Ltd., BlueNRGY Group LTD, G Medical Innovations Holdings Ltd.
NEITHER THIS WARRANT NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...G Medical Innovations Holdings Ltd. • October 22nd, 2020 • Surgical & medical instruments & apparatus
THIS AGENT’S WARRANT (this “Warrant”) certifies that, for value received, [ ], the registered holder hereof or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the period on or after the issuance date of this Warrant (the “Initial Exercise Date”) and until the close of business on the five (5) year anniversary (the “Termination Date”) of the Effective Date (as defined in Section 2(e)), but not thereafter, to subscribe for and purchase from G MEDICAL INNOVATIONS HOLDINGS LTD., a Cayman Islands exempted company (the “Company”), up to [●]2 (as subject to adjustment hereunder, the “Warrant Shares”) ordinary shares, par value $0.018 per share, of the Company (the “Ordinary Shares”). The purchase price of one Warrants Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...May 5th, 2020
THIS ORDINARY SHARE PURCHASE WARRANT (this “Warrant”) certifies that, for value received, ESOL, B.V. (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December 31, 2015 (the “Initial Exercise Date”) and on or prior to the close of business on the Three (3) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BlueNRGY Group Limited, an Australian corporation (the “Company”), up to 26,470,079 shares (the “Warrant Shares”) of the Company’s ordinary shares (the “Ordinary Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
ORDINARY SHARE PURCHASE WARRANT BLUENRGY GROUP LIMITEDBlueNRGY Group LTD • December 10th, 2015 • Construction - special trade contractors
THIS ORDINARY SHARE PURCHASE WARRANT (this “Warrant”) certifies that, for value received, ESOL, B.V. (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December 31, 2015 (the “Initial Exercise Date”) and on or prior to the close of business on the Three (3) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BlueNRGY Group Limited, an Australian corporation (the “Company”), up to 26,470,079 shares (the “Warrant Shares”) of the Company’s ordinary shares (the “Ordinary Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES B ORDINARY SHARES PURCHASE WARRANT ROSETTA GENOMICS LTD.Rosetta Genomics Ltd. • October 14th, 2011 • Pharmaceutical preparations
THIS SERIES B ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, on the 11th Trading Day following the Effective Date (as defined in the Purchase Agreement) (the “Exercise Date”) to receive from Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), up to ______ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”) according to the vesting schedule set forth below. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b) and shall be exercised only via cashless exercise pursuant to Section 2(c) below. On the Exercise Date a number of Warrant Shares shall vest under this Warrant equal to the difference between (a) the quotient obtained by dividing (1) 200% of the maximu
SERIES B ORDINARY SHARES PURCHASE WARRANT ROSETTA GENOMICS LTD.Rosetta Genomics Ltd. • November 30th, 2010 • Pharmaceutical preparations
THIS SERIES B ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, on the 33rd Trading Day following the Effective Date (as defined in the Purchase Agreement) (the “Exercise Date”) to receive from Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), up to ______ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”) according to the vesting schedule set forth below. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b) and shall be exercised only via cashless exercise pursuant to Section 2(c) below. On the Exercise Date a number of Warrant Shares shall vest under this Warrant equal to the product of (a) the maximum number of Warrant Shares issuable under this Warrant
